Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) has shared an announcement.
Concord Healthcare Group Co., Ltd. has formed a strategic partnership with the Hong Kong and Macau branches of AIA International Limited. This collaboration allows eligible insured members of AIA’s designated group insurance to access affordable cancer proton therapy and health screening packages at the Guangzhou Concord Cancer Center. The partnership aligns with AIA’s strategy to enhance employee wellbeing and marks a significant step in Concord Healthcare’s strategic deployment within the health ecosystem, potentially impacting its market positioning by expanding access to quality healthcare services.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$5.50 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the healthcare industry. The company, along with its subsidiaries, focuses on providing comprehensive cancer and health-related services, with a flagship institution being the Guangzhou Concord Cancer Center.
Average Trading Volume: 14,525,009
Technical Sentiment Signal: Sell
Find detailed analytics on 2453 stock on TipRanks’ Stock Analysis page.